Skip to main content
Top
Published in: Comparative Clinical Pathology 2/2020

01-04-2020 | Buprenorphine | Original Article

The effect of methadone, buprenorphine, and shift of methadone to buprenorphine on sperm parameters and antioxidant activity in a male rat model

Authors: Mohammadreza Haddadi, Jafar Ai, Sadegh Shirian, Ali Kadivar, Maryam Farahmandfar

Published in: Comparative Clinical Pathology | Issue 2/2020

Login to get access

Abstract

Methadone and buprenorphine are two widely used substances for opioid-based detoxification. The aim of the present study was to examine the effects of buprenorphine and methadone on the redox status of testicular tissue, sperm parameter analysis, and hormonal changes in a rat model. A total of 40 male Wistar rats (220–250 g) were randomly divided into four groups: methadone, buprenorphine, shift of methadone to buprenorphine, and control groups. At days 21 and 42 post-treatment, the animals (n = 5 for each time) were deeply anesthetized, blood sera were isolated, and testes of the rats were dissected out. The levels of blood total testosterone (TT), free testosterone (FT), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) as well as antioxidant enzymes activity in the testicular tissue were measured. Sperm parameters, including sperm viability, motility, and count, were calculated and compared between the groups. Both buprenorphine and methadone treatments induced oxidative stress, suppressed sperm parameters, and resulted in sexual hormone dysfunction compared with the control group. The highest levels of alterations were detected in the shift group. In conclusion, methadone and buprenorphine enhanced testicular oxidative stress, suppressed blood levels of sexual hormone, including LH, FSH, TT, and FT, and resulted in suppressed sperm parameters. There were no significant differences between methadone and buprenorphine treatments in terms of their adverse effects on sperm parameters and antioxidant activity. However, shift of methadone to buprenorphine resulted in the worst adverse effect in the male reproductive system in the rat model.
Literature
go back to reference Ahmadnia H, Akhavan Rezayat A, Hoseyni M, Sharifi N, Khajedalooee M, Akhavan Rezayat A (2016) Short-period influence of chronic morphine exposure on serum levels of sexual hormones and spermatogenesis in rats. Nephrourol Mon 8(4):e38052CrossRef Ahmadnia H, Akhavan Rezayat A, Hoseyni M, Sharifi N, Khajedalooee M, Akhavan Rezayat A (2016) Short-period influence of chronic morphine exposure on serum levels of sexual hormones and spermatogenesis in rats. Nephrourol Mon 8(4):e38052CrossRef
go back to reference Bawor M, Dennis BB, Samaan MC, Plater C, Worster A, Varenbut M, Daiter J, Marsh DC, Desai D, Steiner M, Anglin R, Coote M, Pare G, Thabane L, Samaan Z (2014) Methadone induces testosterone suppression in patients with opioid addiction. Sci Rep 4:6189CrossRef Bawor M, Dennis BB, Samaan MC, Plater C, Worster A, Varenbut M, Daiter J, Marsh DC, Desai D, Steiner M, Anglin R, Coote M, Pare G, Thabane L, Samaan Z (2014) Methadone induces testosterone suppression in patients with opioid addiction. Sci Rep 4:6189CrossRef
go back to reference Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmüller D (2005) Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 90:203–206CrossRef Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmüller D (2005) Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 90:203–206CrossRef
go back to reference Brown RT, Zueldorf M (2007) Opioid substitution with methadone and buprenorphine: sexual dysfunction as a side effect of therapy. Heroin Addict Relat Clin Probl 9(1):35–44 Brown RT, Zueldorf M (2007) Opioid substitution with methadone and buprenorphine: sexual dysfunction as a side effect of therapy. Heroin Addict Relat Clin Probl 9(1):35–44
go back to reference Cicero TJ, Davis LA, LaRegina MC, Meyer ER, Schlegel MS (2002) Chronic opiate exposure in the male rat adversely affects fertility. Pharmacol Biochem Behav 72(1–2):157–163CrossRef Cicero TJ, Davis LA, LaRegina MC, Meyer ER, Schlegel MS (2002) Chronic opiate exposure in the male rat adversely affects fertility. Pharmacol Biochem Behav 72(1–2):157–163CrossRef
go back to reference Gabrielsen JS, Tanrikut C (2016) Chronic exposures and male fertility: the impacts of environment, diet, and drug use on spermatogenesis. Andrology. 4(4):648–661CrossRef Gabrielsen JS, Tanrikut C (2016) Chronic exposures and male fertility: the impacts of environment, diet, and drug use on spermatogenesis. Andrology. 4(4):648–661CrossRef
go back to reference Ganjalikhan Hakemi S, Sharififar F, Haghpanah T, Babaee A, Eftekhar-Vaghefi SH (2019) The effects of olive leaf extract on the testis, sperm quality and testicular germ cell apoptosis in male rats exposed to busulfan. Int J Fertil Steril 13(1):57–65PubMedPubMedCentral Ganjalikhan Hakemi S, Sharififar F, Haghpanah T, Babaee A, Eftekhar-Vaghefi SH (2019) The effects of olive leaf extract on the testis, sperm quality and testicular germ cell apoptosis in male rats exposed to busulfan. Int J Fertil Steril 13(1):57–65PubMedPubMedCentral
go back to reference Ghelardini C, Mannelli LDC, Bianchi E (2015) The pharmacological basis of opioids. Clin Cases Miner Bone Metab 12(3):219–221PubMedPubMedCentral Ghelardini C, Mannelli LDC, Bianchi E (2015) The pharmacological basis of opioids. Clin Cases Miner Bone Metab 12(3):219–221PubMedPubMedCentral
go back to reference Ghowsi M, Yousofvand N (2015) Impact of morphine dependency and detoxification by methadone on male’s rat reproductive system. Iran J Reprod Med 13(5):275–282PubMedPubMedCentral Ghowsi M, Yousofvand N (2015) Impact of morphine dependency and detoxification by methadone on male’s rat reproductive system. Iran J Reprod Med 13(5):275–282PubMedPubMedCentral
go back to reference Hallinan R, Byrne A, Agho K, McMahon CG, Tynan P, Attia J (2009) Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 32(2):131–139CrossRef Hallinan R, Byrne A, Agho K, McMahon CG, Tynan P, Attia J (2009) Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 32(2):131–139CrossRef
go back to reference Heidari Z, Mahmoudzadeh-Sagheb H, Kohan F (2012) A quantitative and qualitative study of rat testis following administration of methadone and buprenorphine. Int J High Risk Behav Addiction 2012:12–15CrossRef Heidari Z, Mahmoudzadeh-Sagheb H, Kohan F (2012) A quantitative and qualitative study of rat testis following administration of methadone and buprenorphine. Int J High Risk Behav Addiction 2012:12–15CrossRef
go back to reference Jones JL, Mateus CF, Malcolm RJ, Brady KT, Back SE (2018) Efficacy of ketamine in the treatment of substance use disorders: a systematic review. Front Psychiatry 24(9):277CrossRef Jones JL, Mateus CF, Malcolm RJ, Brady KT, Back SE (2018) Efficacy of ketamine in the treatment of substance use disorders: a systematic review. Front Psychiatry 24(9):277CrossRef
go back to reference Leary S, Underwood W, Anthony R, Cartner S, Corey D, Grandin T, Greenacre CB, Gwaltney-Bran S, McCrackin MA, Meyer R (2013) AVMA guidelines for the euthanasia of animals: 2013 edition. Leary S, Underwood W, Anthony R, Cartner S, Corey D, Grandin T, Greenacre CB, Gwaltney-Bran S, McCrackin MA, Meyer R (2013) AVMA guidelines for the euthanasia of animals: 2013 edition.
go back to reference Leventelis C, Goutzourelas N, Kortsinidou A, Spanidis Y, Toulia G, Kampitsi A, Tsitsimpikou C, Stagos D, Veskoukis AS, Kouretas D (2019) Buprenorphine and methadone as opioid maintenance treatments for heroin-addicted patients induce oxidative stress in blood. Oxidative Med Cell Longev 2019:9417048CrossRef Leventelis C, Goutzourelas N, Kortsinidou A, Spanidis Y, Toulia G, Kampitsi A, Tsitsimpikou C, Stagos D, Veskoukis AS, Kouretas D (2019) Buprenorphine and methadone as opioid maintenance treatments for heroin-addicted patients induce oxidative stress in blood. Oxidative Med Cell Longev 2019:9417048CrossRef
go back to reference Marchetti F, Aardema M, Beevers C, Yauk CL, Young R, Williams A (2018) Simulation of mouse and rat spermatogenesis to inform genotoxicity testing using OECD test guideline 488. Mutat Res 832-833:19–28CrossRef Marchetti F, Aardema M, Beevers C, Yauk CL, Young R, Williams A (2018) Simulation of mouse and rat spermatogenesis to inform genotoxicity testing using OECD test guideline 488. Mutat Res 832-833:19–28CrossRef
go back to reference Salarian A, Kadkhodaee M, Zahmatkesh M, Seifi B, Bakhshi E, Akhondzadeh S, Adeli S, Askari H, Arbabi M (2018) Opioid use disorder induces oxidative stress and inflammation: the attenuating effect of methadone maintenance treatment. Iran J Psychiatry 13(1):46–54PubMedPubMedCentral Salarian A, Kadkhodaee M, Zahmatkesh M, Seifi B, Bakhshi E, Akhondzadeh S, Adeli S, Askari H, Arbabi M (2018) Opioid use disorder induces oxidative stress and inflammation: the attenuating effect of methadone maintenance treatment. Iran J Psychiatry 13(1):46–54PubMedPubMedCentral
go back to reference Sharma R, Biedenharn K, Fedor J, Agarwal A (2013) Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol 11:664 Sharma R, Biedenharn K, Fedor J, Agarwal A (2013) Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol 11:664
go back to reference Strain EC (2006) Pharmacology of buprenorphine. In: Strain EC, Stitzer ML (eds) The treatment of opioid dependence. Johns Hopkins Press, Baltimore, pp 213–229 Strain EC (2006) Pharmacology of buprenorphine. In: Strain EC, Stitzer ML (eds) The treatment of opioid dependence. Johns Hopkins Press, Baltimore, pp 213–229
go back to reference United Nations Office on Drugs and Crime (2014) World drug report. United Nations, Vienna United Nations Office on Drugs and Crime (2014) World drug report. United Nations, Vienna
go back to reference Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T (2013) Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet. 382(9904):1575–1586CrossRef Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T (2013) Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet. 382(9904):1575–1586CrossRef
go back to reference Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG (2016) Sexual dysfunction in heroin dependents: a comparison between methadone and buprenorphine maintenance treatment. PLoS One 11(1):e0147852CrossRef Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG (2016) Sexual dysfunction in heroin dependents: a comparison between methadone and buprenorphine maintenance treatment. PLoS One 11(1):e0147852CrossRef
go back to reference Yee A, Loh HS, Danaee M, Riahi S, Ng CG, Sulaiman AH (2018) Plasma testosterone and sexual function in southeast Asian men receiving methadone and buprenorphine maintenance treatment. J Sex Med 15(2):159–166CrossRef Yee A, Loh HS, Danaee M, Riahi S, Ng CG, Sulaiman AH (2018) Plasma testosterone and sexual function in southeast Asian men receiving methadone and buprenorphine maintenance treatment. J Sex Med 15(2):159–166CrossRef
Metadata
Title
The effect of methadone, buprenorphine, and shift of methadone to buprenorphine on sperm parameters and antioxidant activity in a male rat model
Authors
Mohammadreza Haddadi
Jafar Ai
Sadegh Shirian
Ali Kadivar
Maryam Farahmandfar
Publication date
01-04-2020
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 2/2020
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-019-03054-2

Other articles of this Issue 2/2020

Comparative Clinical Pathology 2/2020 Go to the issue